✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Wockhardt Ltd.

WOCKPHARMA

Market Cap
₹25,528 Cr.
P/E
119.85

Wockhardt Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
25,528 Cr
PE
PE
119
Prom Holding
Prom Holding
49.08 %
ROE (%)
ROE (%)
-
ROCE (%)
ROCE (%)
4.29
Div Yield (%)
Div Yield (%)
-
Sales
Sales
3,373 Cr
OPM (%)
OPM (%)
19.33 %
Debt to Equity
Debt to Equity
0.43
Institutions
Institutions
18.08 %
Individual < 2 lac
Individual < 2 lac
18.87 %
No. of Shareholders
No. of Shareholders
1.39 L
View more
Edit Ratio's

About

Wockhardt Limited is a global pharmaceutical and biotechnology organisation, providing afforda… Read more
Low
1087
52W Range
High
1869
  • Wockhardt
  • Gland Pharma
  • Pfizer
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New
Edit rows

Forensics

9 Yes

Positive for this company

1 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share

0.69 %
(as of Jul 22)
Historic
Anti - Diabetes - Market Share
0.05 %
(as of Jul 22)
Historic
Anti-Infectives - Market Share
0.01 %
(as of Aug 20)
Historic
Anti-Malarial - Market Share
0.05 %
(as of Nov 21)
Historic
Antineo Plastic - Market Share
4.31 %
(as of Nov 21)
Historic
Blood Related - Market Share
0 %
(as of Jul 22)
Historic
Cardiovascular - Market Share

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Asset Break-Up

Operational Metrics

    locked
    Select a Metric
    • Domestic Sales Growth - YoY (%)
      Source
    • R&D as a % of Total Sales (%)
      Source

    Peer Comparison

    Brands

    Spasmo Proxyvon

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    Suppliers

    • Shaily Engineering Plastics Ltd.
    • Borosil Renewables Ltd.
    • Responsive Industries Ltd.
    • Hindusthan National Glass & Industries Ltd.
    • Vivimed Labs Ltd.

    FAQs on Wockhardt Ltd. Business

    Wockhardt Limited is a prominent Indian pharmaceutical and biotechnology company that prioritizes accessibility to high-quality medicines. They are active in Pharmaceuticals, Biotechnology, and Super Speciality Hospitals.

    Wockhardt major competitors are Gland Pharma, Pfizer, Natco Pharma, Astrazeneca Pharma I, Eris Lifesciences, JB Chem & Pharma, Jubilant Pharmova.
    Market Cap of Wockhardt is ₹25,528 Crs.
    While the median market cap of its peers are ₹21,165 Crs.

    Wockhardt seems to be less financially stable compared to its competitors.
    Altman Z score of Wockhardt is 6.21 and is ranked 6 out of its 8 competitors.

    View FAQ's On Shareprice

    Company Filing

    Discussions & Analysis

    Wockhardt Ltd.
    Why Aditya Khemka Is Skeptical About Wockhardt's NCE Story - Accidental Investor Prince
    View The Discussion On ValuePickr - ValuePickr
    Pharmaceuticals
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Nutraceuticals- Industry Overview - Value Educator
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Pharma Compliance In-Depth - Amit Rajan
    Deep Dive into Pharma Sector - Omkara Capital
    How The Pharma Industry Works - PPFAS
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material